About
Natali Aziz, M.D., M.S., is a Clinical Associate Professor in the Department of Obstetrics and Gynecology (Maternal Fetal Medicine) at Stanford University. She holds dual board certifications from the American Board of Obstetrics and Gynecology in Obstetrics/Gynecology (2008) and Maternal-Fetal Medicine (2011). Her clinical practice focuses on high-risk pregnancies, reproductive infectious diseases, and perinatal diagnostics.
Education includes:
- Medical Education: Stanford University School of Medicine (2000)
- Internship & Residency: Stanford University Obstetrics and Gynecology (2001-2004)
- Fellowship: UCSF Maternal Fetal Medicine (2008)
Dr. Aziz's research centers on infectious disease impacts during pregnancy, particularly COVID-19 pathophysiology, intraamniotic infection biomarkers, and therapeutic interventions. Her work emphasizes health disparities, antiviral efficacy, and immune system adaptations in gestation. She maintains active investigations into pandemic-era clinical management protocols.
Recent publications (2019-2024) demonstrate strong focus on COVID-19 complications in pregnancy, including vaccine acceptance studies, hepatic manifestations, and fetal therapeutic innovations. Secondary themes include preterm birth predictors and immunological changes during gestation.
Teaching responsibilities include directing independent studies across academic levels:
- OBGYN 299 (Directed Reading)
- OBGYN 280 (Early Clinical Experience)
- OBGYN 399/370 (Graduate/Medical Scholars Research)
- OBGYN 199 (Undergraduate Research)